Newsfile Corp
02 Aug 2026, 15:13 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ADMA Biologics is accused in a securities class action lawsuit of using channel stuffing to artificially inflate revenue. — Allegations of revenue manipulation through channel stuffing are severe and typically lead to significant loss of investor trust and stock price devaluation.
-0.80The lawsuit alleges that ADMA Biologics engaged in undisclosed related party transactions and lacked adequate internal controls. — Poor internal controls and hidden related-party deals suggest systemic governance failures and potential financial reporting inaccuracies.
-0.60A deadline of August 10, 2026, has been set for investors to move to serve as lead plaintiff in the class action lawsuit. — This is a procedural legal milestone that confirms the litigation is advancing but does not inherently change the company's fundamentals.
-0.10Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is facing a securities class action lawsuit alleging channel stuffing and misleading statements.
The company is mentioned in the context of a securities class action investigation.
The company is facing a securities class action lawsuit with an upcoming lead plaintiff deadline.
Mentioned as a dominant player in AI activity engaging with corporate news.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
1h ago
